Company intelligence / Profile preview

Mount Morris Advisors

Ownership: Private
Development stage: Other

Overview

Mount Morris Advisors is a boutique finance and corporate development resource that supports early-stage private life science companies. It offers independent advice on capital raising, deal structuring, exit strategies, and can act as CFO resource for startups in biotech/pharma/healthcare sectors. It does not have its own drug pipeline or therapeutic programs but works alongside management teams of life science firms, providing financial advisory services. No clinical results or drug development data are associated with this entity.

Industry: Consulting

Partnerships

No specific pharma/biotech partnerships disclosed; acts as an advisor to early stage life science companies generally

Beyond the preview

Go deeper on Mount Morris Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mount Morris Advisors.

Explore the full profile